Variant report

Variant	nsv481687
Chromosome Location	chr6:162606492-163026721
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:162794306-162794665	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:162857639-162857816	HepG2	liver:	n/a	n/a
3	ARID3A	chr6:162910482-162910786	HepG2	liver:	n/a	n/a
4	ARID3A	chr6:162671087-162671724	HepG2	liver:	n/a	n/a
5	ATF1	chr6:162812215-162812339	K562	blood:	n/a	n/a
6	ATF1	chr6:162784797-162785113	K562	blood:	n/a	n/a
7	ATF1	chr6:162782228-162782581	K562	blood:	n/a	n/a
8	ATF1	chr6:162812647-162812847	K562	blood:	n/a	n/a
9	ATF3	chr6:162784742-162785052	K562	blood:	n/a	n/a
10	BACH1	chr6:162975725-162976098	K562	blood:	n/a	n/a
11	BHLHE40	chr6:162899266-162899534	GM12878	blood:	n/a	n/a
12	BRCA1	chr6:162658617-162658742	Hela-S3	cervix:	n/a	n/a
13	BRCA1	chr6:162871740-162871751	H1-hESC	embryonic stem cell:	n/a	n/a
14	CBX3	chr6:162785538-162785848	K562	blood:	n/a	n/a
15	CBX3	chr6:162784775-162785143	K562	blood:	n/a	n/a
16	CCNT2	chr6:163001825-163002025	K562	blood:	n/a	n/a
17	CEBPB	chr6:162871443-162871750	MCF-7	breast:	n/a	chr6:162871605-162871616
18	CEBPB	chr6:162675613-162675797	A549	lung:	n/a	chr6:162675652-162675661 chr6:162675652-162675661 chr6:162675652-162675663 chr6:162675650-162675661 chr6:162675652-162675661 chr6:162675650-162675663 chr6:162675652-162675661
19	CEBPB	chr6:162876249-162876534	IMR90	lung:	n/a	n/a
20	CEBPB	chr6:162794250-162794499	HepG2	liver:	n/a	chr6:162794312-162794323
21	CEBPB	chr6:162779076-162779247	A549	lung:	n/a	chr6:162779118-162779129
22	CEBPB	chr6:162857234-162857635	HepG2	liver:	n/a	chr6:162857420-162857431
23	CEBPB	chr6:162839236-162839248	A549	lung:	n/a	n/a
24	CEBPB	chr6:162671564-162671902	A549	lung:	n/a	n/a
25	CEBPB	chr6:162784733-162785018	K562	blood:	n/a	n/a
26	CEBPB	chr6:162672448-162672478	HepG2	liver:	n/a	n/a
27	CEBPB	chr6:162825981-162826255	HepG2	liver:	n/a	chr6:162826093-162826104
28	CEBPB	chr6:162910422-162910805	HepG2	liver:	n/a	n/a
29	CEBPB	chr6:162766332-162766577	H1-hESC	embryonic stem cell:	n/a	chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493
30	CEBPB	chr6:162766335-162766614	A549	lung:	n/a	chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493
31	CEBPB	chr6:162784839-162785153	HepG2	liver:	n/a	chr6:162785029-162785040
32	CEBPB	chr6:162939387-162939585	HepG2	liver:	n/a	chr6:162939453-162939464
33	CEBPB	chr6:162944101-162944302	HepG2	liver:	n/a	n/a
34	CEBPB	chr6:162634250-162634590	HepG2	liver:	n/a	chr6:162634418-162634429
35	CEBPB	chr6:162961979-162962215	HepG2	liver:	n/a	chr6:162962080-162962091
36	CEBPB	chr6:162671584-162671889	IMR90	lung:	n/a	n/a
37	CEBPB	chr6:162857299-162857541	HepG2	liver:	n/a	chr6:162857420-162857431
38	CEBPB	chr6:162766327-162766640	HepG2	liver:	n/a	chr6:162766482-162766491 chr6:162766482-162766491 chr6:162766481-162766492 chr6:162766482-162766491 chr6:162766480-162766491 chr6:162766482-162766491 chr6:162766480-162766493
39	CEBPB	chr6:162861366-162861450	H1-hESC	embryonic stem cell:	n/a	chr6:162861390-162861403
40	CEBPB	chr6:162656180-162656471	HepG2	liver:	n/a	chr6:162656287-162656298 chr6:162656286-162656299
41	CEBPB	chr6:162652593-162652906	HepG2	liver:	n/a	chr6:162652751-162652762
42	CEBPB	chr6:162857291-162857590	HepG2	liver:	n/a	chr6:162857420-162857431
43	CEBPB	chr6:162671554-162671904	HepG2	liver:	n/a	n/a
44	CEBPB	chr6:162634276-162634544	A549	lung:	n/a	chr6:162634418-162634429
45	CEBPB	chr6:162784873-162785124	H1-hESC	embryonic stem cell:	n/a	chr6:162785029-162785040
46	CEBPB	chr6:162871496-162871684	HepG2	liver:	n/a	chr6:162871605-162871616
47	CEBPB	chr6:162784761-162785142	K562	blood:	n/a	chr6:162785029-162785040
48	CEBPB	chr6:162726891-162727117	HepG2	liver:	n/a	chr6:162726998-162727009 chr6:162726998-162727011 chr6:162727074-162727083 chr6:162727018-162727029 chr6:162727072-162727085
49	CEBPB	chr6:162675529-162675821	HepG2	liver:	n/a	chr6:162675652-162675661 chr6:162675652-162675661 chr6:162675652-162675663 chr6:162675650-162675661 chr6:162675652-162675661 chr6:162675650-162675663 chr6:162675652-162675661
50	CEBPB	chr6:162871405-162871712	H1-hESC	embryonic stem cell:	n/a	chr6:162871605-162871616

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:162683961-162684011	HRCEpiC	kidney:	n/a
2	chr6:162683961-162684011	HRCEpiC	kidney:	n/a
3	chr6:162864586-162864636	HCM	heart:	n/a
4	chr6:162684526-162684576	ovcar-3	ovarian:	n/a
5	chr6:162865171-162865221	HEEpiC	esophagus:	n/a
6	chr6:162684441-162684491	HL-60	blood:	n/a
7	chr6:162831837-162831887	Jurkat	blood:	n/a
8	chr6:162683857-162683907	GM12878	blood:	n/a
9	chr6:162865258-162865308	NHBE	bronchial:	n/a
10	chr6:162683961-162684011	SK-N-MC	brain:	n/a
11	chr6:162865258-162865308	CMK	blood:	n/a
12	chr6:162683881-162683931	HCM	heart:	n/a
13	chr6:162684526-162684576	HRCEpiC	kidney:	n/a
14	chr6:162865258-162865308	AG04450	lung:	fetal
15	chr6:162863505-162863555	HRCEpiC	kidney:	n/a
16	chr6:162865258-162865308	HAEpiC	amniotic membrane:	n/a
17	chr6:162683881-162683931	SK-N-SH_RA	brain:	n/a
18	chr6:162684441-162684491	BE2_C	brain:	n/a
19	chr6:163024624-163024674	Jurkat	blood:	n/a
20	chr6:162684441-162684491	Hepatocyte	liver:	n/a
21	chr6:162865171-162865221	RPTEC	kidney:	n/a
22	chr6:162683961-162684011	GM19239	blood:	n/a
23	chr6:162865258-162865308	GM12892	blood:	n/a
24	chr6:162684526-162684576	ECC-1	luminal epithelium:	n/a
25	chr6:162684441-162684491	ECC-1	luminal epithelium:	n/a
26	chr6:163024624-163024674	IMR90	lung:	fetal
27	chr6:162864586-162864636	GM19239	blood:	n/a
28	chr6:162683961-162684011	T-47D	breast:	n/a
29	chr6:162865171-162865221	BE2_C	brain:	n/a
30	chr6:162865258-162865308	HIPEpiC	eye:	n/a
31	chr6:162683961-162684011	AG10803	skin:	n/a
32	chr6:162831837-162831887	HIPEpiC	eye:	n/a
33	chr6:162865171-162865221	HNPCEpiC	eye:	n/a
34	chr6:162864586-162864636	CMK	blood:	n/a
35	chr6:162964378-162964428	PrEC	prostate:	n/a
36	chr6:162865258-162865308	K562	blood:	n/a
37	chr6:162864586-162864636	HRPEpiC	eye:	n/a
38	chr6:162863505-162863555	Hela-S3	cervix:	n/a
39	chr6:163024624-163024674	H1-hESC	embryonic stem cell:	embryo
40	chr6:162964378-162964428	GM06990	blood:	n/a
41	chr6:162683881-162683931	Caco-2	colon:	n/a
42	chr6:163024624-163024674	ovcar-3	ovarian:	n/a
43	chr6:162865171-162865221	HPAEpiC	pulmonary alveolar:	n/a
44	chr6:162683881-162683931	A549	lung:	n/a
45	chr6:162684526-162684576	NH-A	brain:	n/a
46	chr6:162865171-162865221	K562	blood:	n/a
47	chr6:162865258-162865308	AG09309	skin:	n/a
48	chr6:162684441-162684491	MCF10A-Er-Src	breast:	n/a
49	chr6:162683961-162684011	HRE	kidney:	n/a
50	chr6:162684441-162684491	MCF-7	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:162863367..162864320-chr6:163157771..163158572,4	MCF-7	breast:
2	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
3	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:
4	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
5	chr6:162643217..162645721-chr6:162646719..162648950,2	K562	blood:
6	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
7	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
8	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:
9	chr6:163002877..163005708-chr6:163021910..163024946,3	K562	blood:
10	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
11	chr6:162863816..162864618-chr6:163271757..163272511,2	MCF-7	breast:
12	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
13	chr6:163002877..163005708-chr6:163021910..163024946,3	K562	blood:
14	chr6:162666890..162668464-chr6:162670216..162671922,2	K562	blood:
15	chr6:162768506..162770213-chr6:162786241..162788330,2	K562	blood:
16	chr6:162613600..162615384-chr6:162617227..162618872,2	K562	blood:
17	chr6:162902802..162905070-chr6:162905406..162907332,2	K562	blood:
18	chr6:162671180..162673472-chr6:162808694..162811227,2	K562	blood:
19	chr6:162799485..162803733-chr6:162804296..162807777,5	K562	blood:
20	chr6:162763017..162765353-chr6:162767098..162769301,2	K562	blood:
21	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
22	chr6:162902802..162905070-chr6:162905406..162907332,2	K562	blood:
23	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
24	chr6:162960178..162962006-chr6:162962880..162965078,2	K562	blood:
25	chr6:162960178..162962006-chr6:162962880..162965078,2	K562	blood:
26	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:
27	chr6:162721411..162723925-chr6:162726328..162729326,2	K562	blood:
28	chr6:162620407..162622935-chr6:162623040..162625617,2	K562	blood:
29	chr6:162661286..162663139-chr6:162673530..162675376,2	K562	blood:
30	chr6:162820265..162823089-chr6:162827852..162829559,2	K562	blood:

Variant related genes	Relation type
KRT8P44	TF binding region
KRT8P44	CpG island

Extended variants
information (count: 17793 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:17793 , 50 per page) page: 1 2 3 4 5 6 7 ... 356

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs73594241	chr6:162606543-162606544	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs537915463	chr6:162606556-162606557	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs115350326	chr6:162606557-162606558	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs568205991	chr6:162606569-162606570	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs368854967	chr6:162606579-162606580	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs143140411	chr6:162606592-162606593	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs576711999	chr6:162606615-162606616	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs371241538	chr6:162606620-162606621	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs148255839	chr6:162606624-162606625	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs558501440	chr6:162606650-162606651	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs142795458	chr6:162606652-162606653	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs61077870	chr6:162606658-162606659	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs201043683	chr6:162606660-162606661	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs147023079	chr6:162606661-162606662	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs575025256	chr6:162606693-162606694	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs138198493	chr6:162606713-162606714	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs560255797	chr6:162606733-162606734	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs1954944	chr6:162606775-162606776	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs143430071	chr6:162606803-162606804	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs552221620	chr6:162606829-162606830	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs147127451	chr6:162606865-162606866	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs545944188	chr6:162606870-162606871	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs576406875	chr6:162606871-162606872	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs118134519	chr6:162606905-162606906	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs58623893	chr6:162606916-162606917	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs115411486	chr6:162606949-162606950	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs183305210	chr6:162606973-162606974	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs139525708	chr6:162606988-162606989	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs570437218	chr6:162606990-162606991	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs539313640	chr6:162606996-162606997	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs558540392	chr6:162607020-162607021	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs370128513	chr6:162607031-162607032	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs186932184	chr6:162607044-162607045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs376160487	chr6:162607080-162607081	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs191495760	chr6:162607098-162607099	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs540855235	chr6:162607138-162607139	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs61065201	chr6:162607165-162607166	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs577625617	chr6:162607269-162607270	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs546478617	chr6:162607285-162607286	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs562346955	chr6:162607299-162607300	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs372252026	chr6:162607336-162607337	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs573696515	chr6:162607343-162607344	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs5881461	chr6:162607344-162607345	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs74523777	chr6:162607355-162607356	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs397817392	chr6:162607356-162607357	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs397887073	chr6:162607368-162607369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs77977813	chr6:162607399-162607400	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs562021805	chr6:162607418-162607419	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs571826858	chr6:162607444-162607445	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs201694877	chr6:162607451-162607452	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Breast cancer	16397240	CNVD
Atherosclerosis	21956041	CNVD
Maculopathy	20981449	CNVD
Retinoblastoma	22278416	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian cancer	20844748	CNVD
Uveal melanoma	20484589	CNVD
Glioblastoma multiforme	19435819	CNVD
Astrocytoma	16205629	CNVD
Parkinson disease	17160897	CNVD
Cancer	20164920	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	20838587	CNVD
Early-onset parkinson disease	21993715	CNVD
Glioblastoma	18772890	CNVD
Pancreatic cancer	20981101	CNVD
Autism	21360662	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Intellectual disability	22102821	CNVD
Parkinson disease	0	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Parkinson disease	21829596	CNVD
Gastric cancer	22315472	CNVD
Schizophrenia	20967226	CNVD
Schizophrenia	21346763	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
Autism	22495309	CNVD
Glioblastoma multiforme	21138945	CNVD
Ovarian cancer	22355333	CNVD
Schizophrenia	19805367	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:1370 , 50 per page) page: 1 2 3 4 5 6 7 ... 28

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:162591200-162607600	Weak transcription	Right Atrium	heart
2	chr6:162599600-162607800	Weak transcription	Right Ventricle	heart
3	chr6:162600600-162607600	Weak transcription	Left Ventricle	heart
4	chr6:162600800-162607600	Weak transcription	Skeletal Muscle Male	skeletal muscle
5	chr6:162601400-162607600	Weak transcription	Skeletal Muscle Female	skeletal muscle
6	chr6:162603400-162608200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
7	chr6:162605400-162606800	Enhancers	HUVEC	blood vessel
8	chr6:162605800-162624200	Weak transcription	Pancreas	Pancrea
9	chr6:162606200-162609800	Enhancers	Fetal Heart	heart
10	chr6:162607600-162608200	Enhancers	Skeletal Muscle Female	skeletal muscle
11	chr6:162607600-162609600	Enhancers	Left Ventricle	heart
12	chr6:162607600-162609600	Enhancers	Right Atrium	heart
13	chr6:162607600-162609600	Enhancers	Skeletal Muscle Male	skeletal muscle
14	chr6:162607800-162608600	Enhancers	Right Ventricle	heart
15	chr6:162607800-162609600	Enhancers	Psoas Muscle	Psoas
16	chr6:162608200-162608600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr6:162608200-162608600	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
18	chr6:162608200-162608800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
19	chr6:162608200-162609000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr6:162608600-162609600	Enhancers	Skeletal Muscle Female	skeletal muscle
21	chr6:162609600-162612000	Weak transcription	Right Atrium	heart
22	chr6:162609600-162622000	Weak transcription	Left Ventricle	heart
23	chr6:162609600-162622400	Weak transcription	Psoas Muscle	Psoas
24	chr6:162609800-162610800	Weak transcription	Fetal Heart	heart
25	chr6:162610800-162611000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr6:162610800-162612400	Enhancers	Fetal Heart	heart
27	chr6:162612000-162613000	Enhancers	Right Atrium	heart
28	chr6:162612400-162615800	Weak transcription	Fetal Heart	heart
29	chr6:162613000-162621600	Weak transcription	Spleen	Spleen
30	chr6:162613000-162622000	Weak transcription	Right Atrium	heart
31	chr6:162615800-162617200	Enhancers	Fetal Heart	heart
32	chr6:162616200-162616400	Weak transcription	Aorta	Aorta
33	chr6:162616200-162617200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr6:162617200-162621800	Weak transcription	Fetal Heart	heart
35	chr6:162618800-162619200	Enhancers	iPS-18 Cell Line	embryonic stem cell
36	chr6:162619000-162619400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
37	chr6:162619000-162619400	Enhancers	HUES6 Cell Line	embryonic stem cell
38	chr6:162619200-162622000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
39	chr6:162619800-162620000	Enhancers	HUES6 Cell Line	embryonic stem cell
40	chr6:162620600-162620800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr6:162620800-162621400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr6:162620800-162623000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr6:162620800-162623000	Enhancers	Adipose Nuclei	Adipose
44	chr6:162621000-162622800	Enhancers	Skeletal Muscle Female	skeletal muscle
45	chr6:162621200-162622200	Enhancers	Skeletal Muscle Male	skeletal muscle
46	chr6:162621600-162622000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr6:162621600-162622400	Enhancers	Fetal Stomach	stomach
48	chr6:162621800-162622200	Enhancers	Fetal Kidney	kidney
49	chr6:162621800-162623000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
50	chr6:162621800-162623000	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links